Mapping the uncertainties of orphan drugs to advise suitable managed entry agreements: a retrospective analysis
| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Bloem, Lourens | |
| dc.contributor.author | Hulsbosch, Alisa | |
| dc.date.accessioned | 2024-07-02T12:30:24Z | |
| dc.date.available | 2024-07-02T12:30:24Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/46568 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | Het in kaart brengen van de onzekerheden van weesgeneesmiddelen en het creëren van een framework om geschikte managed entry agreements te adviseren om onzekerheden met betrekking tot weesgeneesmiddelen te verminderen. | |
| dc.title | Mapping the uncertainties of orphan drugs to advise suitable managed entry agreements: a retrospective analysis | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Science and Business Management | |
| dc.thesis.id | 24069 |